Alteration in plasma levels of nonprotein sulfhydryl compounds and S-nitrosothiols in chronic renal failure patients

Clinica Chimica Acta

Volumn 327, Issue 1-2, 2003, Pages 87-94

  Włodek, Przemysław J ^a   Kucharczyk, Justyna ^b   Sokołowska, Maria M ^b   Miłkowski, Andrzej ^a   Markiewicz, Adam ^a   Smoleński, Olgierd B ^a   Włodek, Lidia B ^b  

^a Ludwik Rydygier Speciality Hospital in Krakow   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Hemodialysis; Malonyldialdehyde; Nitric oxide; Nonprotein sulfydryl compounds; S Nitrosothiols

Indexed keywords

MALONALDEHYDE; NITRIC OXIDE; S NITROSOTHIOL; THIOL DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; LIPID PEROXIDATION; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; RENAL REPLACEMENT THERAPY; UREMIA;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NITRIC OXIDE; RENAL DIALYSIS; S-NITROSOTHIOLS; SULFHYDRYL COMPOUNDS; UREMIA;

EID: 1842834374     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00339-X     Document Type: Article

References (22)

1. Wang K., Zhang W., Xian M., Hou Y.C., Chen C., Cheng J.P. New chemical and biological aspects of S-nitrosothiols. Curr. Med. Chem. 7:2000;821-834.
2. Stamler J.S. S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups. Koprowski H., Maeda Current topics in microbiology and immunobiology. The role of nitric oxide in physiology and pathophysiology. 1995;19-33 Springer-Verlag, Heidelberg.
3. Broillet M.C. S-nitrosylation of proteins. Cell. Mol. Life Sci. 55:1999;1036-1042.
4. Jourd'heuil D., Hallen K., Feelisch M., Grisham M.B. Dynamic state of S-nitrosothiols in human plasma and whole blood. Free Radic. Biol. Med. 28:2000;409-417.
5. Cuzzocrea S., Zingarelli B., O'Connor M. Effect of buthionine-(SR)-sulfoximine an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite and endotoxic shock-induced vascular failure. Br. J. Pharmacol. 123:1998;525-537.
6. Hon W.M., Lee J.C., Lee K.H. Effect of hemodialysis on plasma nitric oxide levels. Artif. Organs. 24:2000;387-390.
7. Sedlak J., Lindsay R.H. Estimation of protein and nonprotein sulfydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25:1969;192-205.
8. Lowry O.H., Rosenbrough N.J., Randall A.L. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
9. Marzinzig M., Nussler A.K., Stadler J. Improved methods to measure end products of nitric oxide in biological fluid: nitrite, nitrate and S-nitrosothiols. Nitric Oxide: Biol. Chem. 1:1997;177-189.
10. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:1979;351-358.
11. Nishimura M., Takahashi H., Muruyama K.et al. Enhanced production of nitric oxide may be involved in acute hypotension during maintenance hemodialysis. Am. J. Kidney Dis. 31:1998;809-817.
12. Galle J., Wanner C. Oxidative stress and vascular injury - relevant for atherogenesis in uremic patients. Nephrol. Dial. Transplant. 12:1997;2480-2483.
13. Hilliquin P., Borderic D., Hernvann A. Nitric oxide and S-nitrosoproteins in rheumatoid arthritis. Arthritis Rheum. 40:1997;1512-1517.
14. Beltran B., Orsi A., Clementi E., Moncada S. Oxidative stress and S-nitrosylation of proteins in cells. Br. J. Pharmacol. 129:2000;953-960.
15. Rauhula P., Lin A.M., Cuieh C.C. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J. 12:1997;165-172.
16. Hultqvist M., Hegbrand J., Nilsson-Thorell C., Lindholm T., Nilsson P., Linden T.et al. Plasma concentration of vitamin C, vitamin E and/or malonodialdehyde as markers of oxygen free radical production during hemodialysis. Clin. Nephrol. 47:1997;37-46.
17. Nagase S., Aoyagi K., Hirayama A., Gotoh M., Ueda A., Tomida C.et al. Favorable effect of hemodialysis on decreased serum antioxidant activity in hemodialysed patients demonstrated by electron spin resonance. J. Am. Soc. Nephrol. 8:1997;1157-1163.
18. Roselaar S.E., Nanhat N.B., Winyard P.G., Jones P. Detection of oxidants in uremic plasma by electron spin resonance spectroscopy. Kidney Int. 48:1995;199-206.
19. Tepel M., Echelmeyer M., Orie N.N., Zidek W. Increased intracellular reactive oxygen species in patients with end stage renal failure: effect of hemodialysis. Kidney Int. 58:2000;867-872.
20. Włodek J.P., Iciek M.B., Miłkowski A., Smoleński O.B. Various forms of plasma cysteine and its metabolites in patients undergoing hemodialysis. Clin. Chim. Acta. 304:2001;9-18.
21. Clermont G., Lecour S., Lahet J., Siohan P., Vergely C., Chevet D.et al. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysed patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovasc. Res. 47:2000;618-623.
22. Himmelfarb J., McMonagle E., McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int. 58:2000;2571-2578.